Apple said it removed WhatsApp and Threads in its China app offerings Friday on Beijing’s orders, amid technological tensions between the U.S. and China.
Category: China
-
Chinese Exports Are Threatening Biden’s Industrial Agenda
The president is increasingly hitting back with tariffs and other measures meant to restrict imports, raising tensions with Beijing.
-
Congress Ramps Up the Pressure on TikTok
A legislative maneuver in the House may help an effort to force the divestment of the video platform by its Chinese owner, which would squeeze U.S. investors.
-
Biden, Competing With Trump to Be Tough on China, Calls for Steel Tariffs
Speaking to the United Steelworkers union in Pittsburgh, the president urged major increases to some tariffs on steel and aluminum products from China.
-
Biden to Call for Tripling Tariffs on Chinese Steel Products
In a speech to union steelworkers in Pittsburgh, the president will announce several new measures meant to raise new barriers against floods of Chinese imports.
-
Inside Washington’s Role in Microsoft’s Big AI Deal With G42
The White House laid the ground work for Microsoft’s $1.5 billion investment in an Emirati artificial intelligence start-up, a deal meant to box out Beijing.
-
Why Germany Can’t Break Up With China
China remains one of the most important markets for Germany’s export-driven economy, prompting a three-day visit by the German chancellor, who has stressed the importance of open markets.
-
Germany’s Leader, Olaf Scholz, Walks a Fine Line in China
Chancellor Olaf Scholz tried to promote German business interests while delivering warnings from Europe about trade and geopolitical tensions.
-
China’s First Quarter Results Show Growth Propelled by Its Factories
China’s big bet on exports has helped to counteract its housing slowdown, but other countries are worried about a flood of Chinese goods.
-
U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs
Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.
